PharmaTher (PHRM.C) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for ketamine in the treatment of Amyotrophic Lateral Sclerosis (ALS), also…
Food and Drug Administration
Medexus Pharmaceuticals (MDP.T) announced today that medac GmbH, the Company’s licensor for treosulfan, has received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) in response…
Revive Therapeutics (RVV.C) advanced the December 21 deal with Newscope Capital (PHRM.C) past a binding LOI and into a purchase agreement to acquire psilocybin intellectual property from Newscope’s subsidiary,…
Algernon Pharmaceuticals (AGN.C) and Charles River Laboratories agreed to have the latter handle Algernon’s DMT pre-clinical studies for their stroke clinical research program today, according to a press release….
Revive Therapeutics (RVV.C) recent supply agreement with HAVN Life Sciences (HAVN.C) will give them a steady supply of naturally derived psychedelic compounds, like psilocybin, to be used in any…
Creative Medical Technology Holdings (CELZ.OTC) announced proof of concept studies to demonstrate the efficacy and use-value of their ImmCelz immunotherapy product for the treatment of rheumatoid arthritis today. Rheumatoid…
Deep down the insomnia rabbit hole you can hear of some fairly strange recipes for relief. You’ve got your usuals—melatonin pills, valerian root, chamomile tea, CBD—and believe me when…
The ongoing COVID-19 drama that’s dragged markets to its knees may almost be over, as finally companies have made some headway and there’s a drug out there that’s been…
Charlotte’s Web Holdings (CWEB.T) is banding together with six other CBD brands to support ValidCare’s scientific study to answer questions posed by the Food and Drug Administration (FDA) about…
Abbott Laboratories (ABT.NYSE) received Food and Drug Administration (FDA) approval for a new alternative surgical technique for Abbott’s HeartMate 3 heart pump that would allow for more advanced heart…